Cargando…

A validated clinical-genetic score for assessing the risk of thrombosis in patients with COVID-19 receiving thromboprophylaxis

Detalles Bibliográficos
Autores principales:	Soria, José Manuel, Mojal, Sergi, Martinez-Perez, Angel, Acosta, Francisco René, López, Sonia, Miqueleiz, Sara, Rodriguez, Diana, Quijada, Maria Angeles, Cardenas, Antonio, Vidal, Francisco, Remacha, Angel, Antonijoan, Rosa Maria, Souto, Juan Carlos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425308/ https://www.ncbi.nlm.nih.gov/pubmed/35545920 http://dx.doi.org/10.3324/haematol.2022.281068

Ejemplares similares

Impact of pre-admission antithrombotic therapy on disease severity and mortality in patients hospitalized for COVID-19
por: Corrochano, Mariana, et al.
Publicado: (2021)

Impact of increased kidney function on clinical and biological outcomes in real-world patients treated with Direct Oral Anticoagulants
por: Corrochano, Mariana, et al.
Publicado: (2022)

Clinical outcomes in patients with atrial fibrillation treated with DOACs in a specialized anticoagulation center: Critical appraisal of real-world data
por: Moret, Carla, et al.
Publicado: (2023)

Identification of hypercoagulability with thrombelastography in patients with hip fracture receiving thromboprophylaxis
por: You, Daniel, et al.
Publicado: (2021)

Deep vein thrombosis and thromboprophylaxis in arthroscopic anterior cruciate ligament reconstruction
por: Adala, Raviraj, et al.
Publicado: (2011)

Systemic thrombosis in a large cohort of COVID-19 patients despite thromboprophylaxis: A retrospective study
por: Muñoz-Rivas, Nuria, et al.
Publicado: (2021)

Next generation sequencing to dissect the genetic architecture of KNG1 and F11 loci using factor XI levels as an intermediate phenotype of thrombosis
por: Martin-Fernandez, Laura, et al.
Publicado: (2017)

Incidence of Venous Thromboembolism in Hospitalized COVID-19 Patients Receiving Thromboprophylaxis
por: Huang, Jimmy, et al.
Publicado: (2022)

Risk assessment of venous thromboembolism and thromboprophylaxis in pregnant women hospitalized with cancer: Preliminary results from a risk score
por: Hase, Eliane Azeka, et al.
Publicado: (2018)

COVID-19 Associated Coagulopathy: Thrombosis, Hemorrhage and Mortality Rates with an Escalated-Thromboprophylaxis Strategy
por: Daughety, Molly, et al.
Publicado: (2020)

TMAO and Gut Microbial-Derived Metabolites TML and γBB Are Not Associated with Thrombotic Risk in Patients with Venous Thromboembolism
por: Canyelles, Marina, et al.
Publicado: (2022)

Mechanical thromboprophylaxis is sufficient to prevent the lower extremity deep vein thrombosis after kidney transplantation
por: Jun, Kang-Woong, et al.
Publicado: (2014)

COVID-19 associated coagulopathy: Thrombosis, hemorrhage and mortality rates with an escalated-dose thromboprophylaxis strategy
por: Daughety, Molly M., et al.
Publicado: (2020)

Occurrence of Hospital-Associated Thrombosis in the Setting of Current Thromboprophylaxis Strategies: An Observational Cross-Sectional Study
por: Visser, Chantal, et al.
Publicado: (2023)

Thromboprophylaxis in Patients With Cancer and COVID-19
por: Lecumberri, Ramón, et al.
Publicado: (2022)

Thromboprophylaxis in critical care
por: Helms, Julie, et al.
Publicado: (2022)

Electronic alerts, comparative practitioner metrics, and education improve thromboprophylaxis and reduce venous thrombosis in community hospitals
por: Woller, Scott C., et al.
Publicado: (2018)

A Longitudinal Study of Thrombosis and Bleeding Outcomes With Thromboprophylaxis in Pregnant Women at Intermediate and High Risk of VTE
por: Schapkaitz, E., et al.
Publicado: (2023)

Risk factors for and prediction of mortality in critically ill medical–surgical patients receiving heparin thromboprophylaxis
por: Li, Guowei, et al.
Publicado: (2016)

Evaluation of the Khorana Predictive Thrombotic Risk and Thromboprophylaxis Score in Cancer Patients in a Third Level Hospital
por: Bermejo, Lara Almudena Fernández, et al.
Publicado: (2022)

Tumour Cell Lines HT-29 and FaDu Produce Proinflammatory Cytokines and Activate Neutrophils In Vitro: Possible Applications for Neutrophil-Based Antitumour Treatment
por: Brú, Antonio, et al.
Publicado: (2009)

Thromboprophylaxis for Deep Vein Thrombosis and Pulmonary Embolism after Total Joint Arthroplasty in a Low Incidence Population
por: Kim, Kang-Il, et al.
Publicado: (2013)

Massive pulmonary embolism following recovery from COVID-19 infection: inflammation, thrombosis and the role of extended thromboprophylaxis
por: Vadukul, Prakash, et al.
Publicado: (2020)

Incidence and Nature of Lower-Limb Deep Vein Thrombosis in Patients with Polytrauma on Thromboprophylaxis: A Prospective Cohort Study
por: Chowdhury, Sharfuddin, et al.
Publicado: (2021)

The Use of a Scoring System to Guide Thromboprophylaxis in a High-Risk Pregnant Population
por: Schoenbeck, D., et al.
Publicado: (2011)

The cumulative venous thromboembolism incidence and risk factors in intensive care patients receiving the guideline-recommended thromboprophylaxis
por: Zhang, Chuanlin, et al.
Publicado: (2019)

Comparison of Postoperative Bleeding in Total Hip and Knee Arthroplasty Patients Receiving Rivaroxaban, Enoxaparin, or Aspirin for Thromboprophylaxis
por: Lindquist, Desirae E., et al.
Publicado: (2018)

Obstetric Thromboprophylaxis: The Swedish Guidelines
por: Lindqvist, Pelle G., et al.
Publicado: (2011)

Pharmacological thromboprophylaxis and epidural anaesthesia
por: Harsoor, SS, et al.
Publicado: (2012)

Thromboprophylaxis in routine arthroscopy of knee
por: Abouali, Jihad, et al.
Publicado: (2013)

Thromboprophylaxis for Total Knee Arthroplasty
por: Gali, Julio Cesar, et al.
Publicado: (2019)

Thromboprophylaxis after bariatric surgery
por: Almarshad, Feras M., et al.
Publicado: (2020)

Venous Thromboprophylaxis in Spine Surgery
por: Alvarado, Anthony M., et al.
Publicado: (2019)

A survey of thrombosis experts evaluating practices and opinions regarding venous thromboprophylaxis in patients post major abdominal surgery
por: Al Rawahi, Bader, et al.
Publicado: (2017)

Antifactor Xa Levels in Critically Ill Korean Patients Receiving Enoxaparin for Thromboprophylaxis: A Prospective Observational Study
por: Lim, So Yeon, et al.
Publicado: (2013)

COVID-19: opening a new paradigm in thromboprophylaxis for critically ill patients?
por: Ferrandis, Raquel, et al.
Publicado: (2020)

Integrated GWAS and Gene Expression Suggest ORM1 as a Potential Regulator of Plasma Levels of Cell-Free DNA and Thrombosis Risk
por: Lopez, Sonia, et al.
Publicado: (2022)

Thromboprophylaxis during the Pregnancy-Puerperal Cycle - Literature Review
por: Sanches, Suzanna Maria Viana, et al.
Publicado: (2020)

Genetic Determinants of Thrombin Generation and Their Relation to Venous Thrombosis: Results from the GAIT-2 Project
por: Martin-Fernandez, Laura, et al.
Publicado: (2016)

Adequate thromboprophylaxis in critically ill patients
por: Levi, Marcel
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_0q0v3filcjemifrrm47dcctu33